| Item Type | Name |
|
Concept
|
Violence
|
|
Concept
|
Diagnosis, Differential
|
|
Concept
|
Attitude of Health Personnel
|
|
Concept
|
Alprazolam
|
|
Concept
|
Protein Binding
|
|
Concept
|
Activities of Daily Living
|
|
Concept
|
Ambulatory Care
|
|
Concept
|
Receptors, Adrenergic, beta-2
|
|
Concept
|
Diagnosis, Computer-Assisted
|
|
Concept
|
Central Nervous System
|
|
Concept
|
Buspirone
|
|
Concept
|
Clomipramine
|
|
Concept
|
Motor Activity
|
|
Concept
|
Prefrontal Cortex
|
|
Concept
|
Mother-Child Relations
|
|
Concept
|
Fetal Development
|
|
Concept
|
Angina Pectoris
|
|
Concept
|
Iodocyanopindolol
|
|
Concept
|
Humans
|
|
Concept
|
GTP-Binding Protein alpha Subunits, Gi-Go
|
|
Concept
|
Patient Participation
|
|
Concept
|
Brain
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Circadian Rhythm
|
|
Concept
|
Patient Dropouts
|
|
Concept
|
Rats, Inbred Strains
|
|
Concept
|
Absenteeism
|
|
Concept
|
Age of Onset
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Body Weight
|
|
Concept
|
Pharmacogenetics
|
|
Concept
|
Birth Weight
|
|
Concept
|
Alcohol Drinking
|
|
Concept
|
Focus Groups
|
|
Concept
|
Health Knowledge, Attitudes, Practice
|
|
Concept
|
Antidepressive Agents, Second-Generation
|
|
Concept
|
Benzodiazepines
|
|
Concept
|
Complementary Therapies
|
|
Concept
|
Biological Psychiatry
|
|
Concept
|
Serotonin
|
|
Concept
|
GTP-Binding Proteins
|
|
Concept
|
California
|
|
Concept
|
Counseling
|
|
Concept
|
Therapy, Computer-Assisted
|
|
Concept
|
Depression
|
|
Concept
|
Menopause
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Transsexualism
|
|
Concept
|
Georgia
|
|
Concept
|
Aged
|
|
Concept
|
Child of Impaired Parents
|
|
Concept
|
Family
|
|
Concept
|
Patient Acceptance of Health Care
|
|
Concept
|
Buprenorphine
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Cytochrome P-450 Enzyme System
|
|
Concept
|
Postnatal Care
|
|
Concept
|
Attitude to Health
|
|
Concept
|
Calcium
|
|
Concept
|
Anti-Anxiety Agents
|
|
Concept
|
Acute Disease
|
|
Concept
|
Analgesics, Opioid
|
|
Concept
|
Premenopause
|
|
Concept
|
Smoking Cessation
|
|
Concept
|
Heart Defects, Congenital
|
|
Concept
|
Longevity
|
|
Concept
|
Triazoles
|
|
Concept
|
Biomarkers
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
Observer Variation
|
|
Concept
|
Irritable Mood
|
|
Concept
|
Up-Regulation
|
|
Concept
|
Contraceptives, Oral, Combined
|
|
Concept
|
Aggression
|
|
Concept
|
Foundations
|
|
Concept
|
Emergency Service, Hospital
|
|
Concept
|
gamma-Aminobutyric Acid
|
|
Concept
|
Connecticut
|
|
Concept
|
Contraception Behavior
|
|
Concept
|
Crime Victims
|
|
Concept
|
Cerebral Cortex
|
|
Concept
|
Wakefulness
|
|
Concept
|
Antidepressive Agents, Tricyclic
|
|
Concept
|
Ovariectomy
|
|
Concept
|
Sex Offenses
|
|
Concept
|
Embryonic and Fetal Development
|
|
Concept
|
Psychopharmacology
|
|
Concept
|
Blood Platelets
|
|
Concept
|
Alcoholism
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Harm Reduction
|
|
Concept
|
Perinatal Care
|
|
Concept
|
Biomedical Research
|
|
Concept
|
Infant Behavior
|
|
Concept
|
Suicide
|
|
Concept
|
Mothers
|
|
Concept
|
Lithium Carbonate
|
|
Concept
|
Attention
|
|
Concept
|
Rhode Island
|
|
Concept
|
Family Planning Services
|
|
Concept
|
Amygdala
|
|
Concept
|
Drug Users
|
|
Concept
|
Smoking
|
|
Concept
|
Delivery of Health Care, Integrated
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Massachusetts
|
|
Concept
|
Health Care Costs
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Health Behavior
|
|
Concept
|
1-Naphthylamine
|
|
Concept
|
Cost-Benefit Analysis
|
|
Concept
|
MEDLINE
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Social Behavior
|
|
Concept
|
Patient Compliance
|
|
Concept
|
Maternal Health Services
|
|
Concept
|
Milk, Human
|
|
Concept
|
Decision Support Systems, Clinical
|
|
Concept
|
Behavior, Addictive
|
|
Concept
|
Insurance Carriers
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Rats
|
|
Concept
|
Stress, Psychological
|
|
Concept
|
Diagnosis, Dual (Psychiatry)
|
|
Concept
|
Pindolol
|
|
Concept
|
Cost of Illness
|
|
Concept
|
Child Abuse, Sexual
|
|
Concept
|
Social Adjustment
|
|
Concept
|
Community Health Centers
|
|
Concept
|
Middle Aged
|
|
Concept
|
Psychophysiology
|
|
Concept
|
United States
|
|
Concept
|
Breast Feeding
|
|
Concept
|
Protein Conformation
|
|
Concept
|
Telemedicine
|
|
Concept
|
Young Adult
|
|
Concept
|
Patient Satisfaction
|
|
Concept
|
Behavioral Symptoms
|
|
Concept
|
Abnormalities, Drug-Induced
|
|
Concept
|
Affective Symptoms
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Receptors, Adrenergic, alpha-2
|
|
Concept
|
Carbamazepine
|
|
Concept
|
Antidepressive Agents
|
|
Concept
|
Mandatory Reporting
|
|
Concept
|
Prenatal Care
|
|
Academic Article
|
Is Preconception Substance Use Associated With Unplanned or Poorly Timed Pregnancy?
|
|
Academic Article
|
Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder.
|
|
Academic Article
|
Assessment of an electronic and clinician-delivered brief intervention on cigarette, alcohol and illicit drug use among women in a reproductive healthcare clinic.
|
|
Academic Article
|
Generalized anxiety disorder in women.
|
|
Academic Article
|
Medical management of premenstrual dysphoric disorder.
|
|
Academic Article
|
Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up.
|
|
Academic Article
|
Premenstrual disorders: bridging research and clinical reality.
|
|
Academic Article
|
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
|
|
Academic Article
|
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.
|
|
Academic Article
|
Lithium During Pregnancy : Drug Effects and Their Therapeutic Implications.
|
|
Academic Article
|
Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up.
|
|
Academic Article
|
The possible effects of depressive symptoms on risk of preterm birth are clouded by lack of control over confounding factors.
|
|
Academic Article
|
Onset and persistence of postpartum depression in an inner-city maternal health clinic system.
|
|
Academic Article
|
Management of bipolar disorder during pregnancy and the postpartum period.
|
|
Academic Article
|
Screening for and detection of depression, panic disorder, and PTSD in public-sector obstetric clinics.
|
|
Academic Article
|
Update on research and treatment of premenstrual dysphoric disorder.
|
|
Academic Article
|
Review: progesterone or progesterone lead to a marginal reduction in premenstrual syndrome symptoms.
|
|
Academic Article
|
The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis.
|
|
Academic Article
|
Perinatal substance use: a prospective evaluation of abstinence and relapse.
|
|
Academic Article
|
New trends in the treatment of anxiety disorders.
|
|
Academic Article
|
Sertraline in the treatment of premenstrual dysphoric disorder.
|
|
Academic Article
|
The infrequency of "pure culture" diagnoses among the anxiety disorders.
|
|
Academic Article
|
Comparing satisfaction, alliance and intervention components in electronically delivered and in-person brief interventions for substance use among childbearing-aged women.
|
|
Academic Article
|
Antidepressants in the treatment of premenstrual dysphoric disorder.
|
|
Academic Article
|
The association between premenstrual dysphoric disorder and other mood disorders.
|
|
Academic Article
|
A descriptive analysis of minor depression.
|
|
Academic Article
|
Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.
|
|
Academic Article
|
Differences in symptom scores and health outcomes in premenstrual syndrome.
|
|
Academic Article
|
Economic evaluation of a behavioral intervention versus brief advice for substance use treatment in pregnant women: results from a randomized controlled trial.
|
|
Academic Article
|
Factors predicting the clinical course of generalised anxiety disorder.
|
|
Academic Article
|
CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome.
|
|
Academic Article
|
Health and economic impact of the premenstrual syndrome.
|
|
Academic Article
|
Prenatal hazardous substance use and adverse birth outcomes.
|
|
Academic Article
|
Typical somatic symptoms of pregnancy and their impact on a diagnosis of major depressive disorder.
|
|
Academic Article
|
Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
|
|
Academic Article
|
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy.
|
|
Academic Article
|
Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women.
|
|
Academic Article
|
See One, Do One, Order One: a study protocol for cluster randomized controlled trial testing three strategies for implementing motivational interviewing on medical inpatient units.
|
|
Academic Article
|
Comparison of major depression diagnostic classification probability using the SCID, CIDI, and MINI diagnostic interviews among women in pregnancy or postpartum: An individual participant data meta-analysis.
|
|
Academic Article
|
Parsing risk for the use of selective serotonin reuptake inhibitors in pregnancy.
|
|
Academic Article
|
Success of mental health referral among pregnant and postpartum women with psychiatric distress.
|
|
Academic Article
|
The psychopharmacological treatment of nonmajor mood disorders.
|
|
Academic Article
|
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
|
|
Academic Article
|
The pharmacologic treatment of depression: is gender a critical factor?
|
|
Academic Article
|
Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
|
|
Academic Article
|
Assessing unipolar mood disorders in women.
|
|
Academic Article
|
Integration of medical and psychological treatment within the primary health care setting.
|
|
Academic Article
|
Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study.
|
|
Academic Article
|
Polyunsaturated Fatty Acids, Highly Unsaturated Fatty Acids, and Perinatal Depression.
|
|
Academic Article
|
Cost and cost-effectiveness of three strategies for implementing motivational interviewing for substance misuse on medical inpatient units.
|
|
Academic Article
|
Management of Agitation During the COVID-19 Pandemic.
|
|
Academic Article
|
Symptom-onset treatment for women with premenstrual dysphoric disorder.
|
|
Academic Article
|
ISPMD consensus on the management of premenstrual disorders.
|
|
Academic Article
|
Trauma and posttraumatic stress disorder in subjects with anxiety disorders.
|
|
Academic Article
|
Phenomenology and course of generalised anxiety disorder.
|
|
Academic Article
|
From Stigma to Validation: A Qualitative Assessment of a Novel National Program to Improve Retention of Physician-Scientists with Caregiving Responsibilities.
|
|
Academic Article
|
A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
|
|
Academic Article
|
Identification of substance use disorders among pregnant women: A comparison of screeners.
|
|
Academic Article
|
Screening for prenatal substance use: development of the Substance Use Risk Profile-Pregnancy scale.
|
|
Academic Article
|
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
|
|
Academic Article
|
The treatment of women suffering from depression who are either pregnant or breastfeeding.
|
|
Academic Article
|
Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up.
|
|
Academic Article
|
Perinatal depression and birth outcomes in a Healthy Start project.
|
|
Academic Article
|
Cost-effectiveness of electronic- and clinician-delivered screening, brief intervention and referral to treatment for women in reproductive health centers.
|
|
Academic Article
|
Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.
|
|
Academic Article
|
Prevalence of medical illness in patients with anxiety disorders.
|
|
Academic Article
|
Case report: menstrual-related very short REM latency in a healthy normal control.
|
|
Academic Article
|
Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes.
|
|
Academic Article
|
Premenstrual syndrome.
|
|
Academic Article
|
Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
|
|
Academic Article
|
The undertreatment of dysthymia.
|
|
Academic Article
|
Venlafaxine in the treatment of premenstrual dysphoric disorder.
|
|
Academic Article
|
Premenstrual dysphoric disorder: evidence for a new category for DSM-5.
|
|
Academic Article
|
A treatment for substance abusing pregnant women.
|
|
Academic Article
|
Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women.
|
|
Academic Article
|
The ties that bind: maternal-infant interactions and the neural circuitry of postpartum depression.
|
|
Academic Article
|
Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study.
|
|
Academic Article
|
Antidepressant use in pregnant and postpartum women.
|
|
Academic Article
|
Evaluating the criteria used for identification of PMS.
|
|
Academic Article
|
Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?
|
|
Academic Article
|
The Most Valuable Resource Is Time: Insights From a Novel National Program to Improve Retention of Physician-Scientists With Caregiving Responsibilities.
|
|
Academic Article
|
Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool.
|
|
Academic Article
|
Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine.
|
|
Academic Article
|
Premenstrual exacerbation of depression: one process or two?
|
|
Academic Article
|
Disordered Eating Among Trans-Masculine Youth: Considerations Through a Developmental Lens.
|
|
Academic Article
|
A literature review of psychotic symptoms associated with the premenstruum.
|
|
Academic Article
|
Quality of life and dissociation in anxiety disorder patients with histories of trauma or PTSD.
|
|
Academic Article
|
Gender differences in chronic major and double depression.
|
|
Academic Article
|
Gender differences in treatment response to sertraline versus imipramine in chronic depression.
|
|
Academic Article
|
Pregnancy-specific stress, preterm birth, and gestational age among high-risk young women.
|
|
Academic Article
|
Generalized anxiety disorder: course and risk factors in pregnancy.
|
|
Academic Article
|
Lack of relationship between menstrual cycle phase and mood in a sample of women with rapid cycling bipolar disorder.
|
|
Academic Article
|
Commentary on Kim et al. (2017): Staying focused on non-treatment seekers.
|
|
Academic Article
|
Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity.
|
|
Academic Article
|
Association of Pregnancy Contexts with Depression and Low Social Support in Early Pregnancy.
|
|
Academic Article
|
A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.
|
|
Academic Article
|
Are pregnancy planning and pregnancy timing associated with maternal psychiatric illness, psychological distress and support during pregnancy?
|
|
Academic Article
|
The expanding medical and behavioral resources with access to care for everyone health plan.
|
|
Academic Article
|
Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
|
|
Academic Article
|
Effects of posttraumatic stress disorder on pregnancy outcomes.
|
|
Academic Article
|
Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.
|
|
Academic Article
|
Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
|
|
Academic Article
|
Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances.
|
|
Academic Article
|
Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder.
|
|
Academic Article
|
An Innovative Program to Support Gender Equity and Success in Academic Medicine: Early Experiences From the Doris Duke Charitable Foundation's Fund to Retain Clinical Scientists.
|
|
Academic Article
|
Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder.
|
|
Academic Article
|
Accuracy of five self-report screening instruments for substance use in pregnancy.
|
|
Academic Article
|
Management strategies for PMS/PMDD.
|
|
Academic Article
|
Symptoms of posttraumatic stress disorder in a community sample of low-income pregnant women.
|
|
Academic Article
|
WFSBP * and IAWMH ** Guidelines for the treatment of alcohol use disorders in pregnant women.
|
|
Academic Article
|
Description of antipanic therapy in a prospective longitudinal study.
|
|
Academic Article
|
Paroxetine as a treatment for premenstrual dysphoric disorder.
|
|
Academic Article
|
Gender differences in presentation of chronic major depression.
|
|
Academic Article
|
Abstinence outcomes among women in reproductive health centers administered clinician or electronic brief interventions.
|
|
Academic Article
|
Special issues related to the treatment of depression in women.
|
|
Academic Article
|
The inclusion of women in psychopharmacologic trials.
|
|
Academic Article
|
Comorbidity of panic and major depressive disorder.
|
|
Academic Article
|
Recognition of depression in obstetric/gynecology practices.
|
|
Academic Article
|
Pharmacotherapy observed in a large prospective longitudinal study on anxiety disorders.
|
|
Academic Article
|
Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication.
|
|
Academic Article
|
Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
|
|
Academic Article
|
Clinical correlates of prescription opioid analgesic use in pregnancy.
|
|
Academic Article
|
Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies.
|
|
Academic Article
|
Using the daily record of severity of problems as a screening instrument for premenstrual syndrome.
|
|
Academic Article
|
Are pregnancy planning and timing associated with preterm or small for gestational age births?
|
|
Academic Article
|
Symptom features of postpartum depression: are they distinct?
|
|
Academic Article
|
Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled Trial.
|
|
Academic Article
|
Evaluation of a social support measure that may indicate risk of depression during pregnancy.
|
|
Academic Article
|
Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes.
|
|
Academic Article
|
Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
|
|
Academic Article
|
Study protocol for the ACT response pilot intervention: development, implementation and evaluation of a systems-based Agitation Code Team (ACT) in the emergency department.
|
|
Academic Article
|
Diagnosis and treatment of premenstrual dysphoric disorder.
|
|
Academic Article
|
More sleep cycles in the mid-luteal phase of a healthy control.
|
|
Academic Article
|
Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
|
|
Academic Article
|
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
|
|
Academic Article
|
Are Adverse Reproductive Outcomes Associated With the Illness or Its Treatment (or Both)?
|
|
Academic Article
|
Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders.
|
|
Academic Article
|
Is the course of panic disorder the same in women and men?
|
|
Academic Article
|
Maternal Antidepressant Use and Pregnancy Outcomes.
|
|
Academic Article
|
Depression screening of perinatal women: an evaluation of the healthy start depression initiative.
|
|
Academic Article
|
An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women.
|
|
Academic Article
|
Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
|
|
Academic Article
|
Mobilizing an institutional supportive response for healthcare workers and other staff in the context of COVID-19: The Yale experience.
|
|
Academic Article
|
The short-term impact on economic outcomes of SBIRT interventions implemented in reproductive health care settings.
|
|
Academic Article
|
Treatment of Psychiatric Conditions in Pregnancy Starts With Planning.
|
|
Academic Article
|
The Collision of Mental Health, Substance Use Disorder, and Suicide.
|
|
Academic Article
|
"A good mother": Impact of motherhood identity on women's substance use and engagement in treatment across the lifespan.
|
|
Academic Article
|
Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics.
|
|
Concept
|
Intimate Partner Violence
|
|
Concept
|
Occupational Stress
|
|
Concept
|
Betacoronavirus
|
|
Concept
|
Cigarette Smoking
|
|
Concept
|
Tobacco Smoking
|
|
Concept
|
Smoking Reduction
|
|
Concept
|
Social Stigma
|
|
Concept
|
Suicidal Ideation
|
|
Concept
|
Marijuana Use
|
|
Concept
|
Motivational Interviewing
|
|
Concept
|
Mindfulness
|
|
Concept
|
Binge Drinking
|
|
Concept
|
Sexism
|
|
Concept
|
Craving
|
|
Academic Article
|
In Reply.
|
|
Academic Article
|
Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review.
|
|
Academic Article
|
Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention.
|
|
Academic Article
|
Qualitative study of patient experiences and care observations during agitation events in the emergency department: implications for systems-based practice.
|
|
Academic Article
|
Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol.
|
|
Academic Article
|
The serotonin reuptake inhibitor fluoxetine induces human fetal membrane sterile inflammation through p38 MAPK activation.
|
|
Academic Article
|
Formative evaluation of an emergency department clinical decision support system for agitation symptoms: a study protocol.
|
|
Academic Article
|
Reporting Perinatal Substance Use to Child Protective Services: Obstetric Provider Perspectives on the Impact on Care.
|
|
Academic Article
|
Buprenorphine induces human fetal membrane sterile inflammation.
|
|
Academic Article
|
Perspectives of the Obstetric Care Environment for Pregnant Individuals Who Have an Opioid Use Disorder.
|
|
Academic Article
|
Hormone-induced conformational changes in the hepatic insulin receptor.
|